BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8066679)

  • 1. Lipoprotein(a) concentrations in chronic renal failure and following renal transplantation.
    Yang CW; Kim YS; Kim SY; Choi EJ; Chang YS; Yoon YS; Bang BK; Koh YB
    Transplant Proc; 1994 Aug; 26(4):2082-3. PubMed ID: 8066679
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid and lipoprotein(a) in renal transplant recipients.
    Sugahara S; Koyama I; Yoshikawa Y; Dohi Y; Omoto R
    Transplant Proc; 1994 Aug; 26(4):2080-1. PubMed ID: 8066678
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a).
    Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T
    Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N; Ohmori Y; Tsuji T; Oka T
    Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of serum lipids, lipoproteins, and fibrinogen in patients with kidney transplantation and hemodialysis.
    Demirağ A; Moray G; Ozdemir N; Hizel N; Bilgin N; Haberal M
    Transplant Proc; 1998 Aug; 30(5):2052-3. PubMed ID: 9723389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
    Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
    Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of lipid anomalies in renal transplantation].
    Mourad G; Vela C; Cristol JP
    Nephrologie; 2000; 21(7):365-6. PubMed ID: 11200613
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
    Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of lipoprotein A in renal transplant recipients.
    Innocenti M; Lorenzetti M; Naldi F; Paleologo G; Pasquariello A; Marchetti P; Giannarelli R; Rindi P; Navalesi R; Rizzo G
    Transplant Proc; 1998 Aug; 30(5):2048. PubMed ID: 9723386
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone.
    Castelao AM; Grinyó JM; Castiñeiras MJ; Fiol C; Gilvernet S; Seron D; Torras J; Cruzado JM; Alsina J
    Transplant Proc; 1995 Aug; 27(4):2217-20. PubMed ID: 7652779
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid metabolism following heterotopic pancreas transplantation with special reference to steroid therapy.
    Cantarovich D; Lucas B; Krempf M; Murat A; Paineau J; Hourmant M; Soulillou JP
    Transplant Proc; 1992 Jun; 24(3):842. PubMed ID: 1604634
    [No Abstract]   [Full Text] [Related]  

  • 18. Dislipidemia at different immunosuppressive protocols.
    Zezina L; Rosental R
    Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection.
    Dimény E; Fellström B; Larsson E; Tufveson G; Lithell H
    Transplant Proc; 1992 Feb; 24(1):366. PubMed ID: 1539319
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid peroxidation in renal allograft recipients.
    Juskowa J; Paczek L; Barańska E; Rancewicz Z; Stryjecka-Rowińska D; Gradowska L; Wyzgał J; Senatorski G; Cieplak M
    Transplant Proc; 1996 Dec; 28(6):3474-6. PubMed ID: 8962351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.